-+ 0.00%
-+ 0.00%
-+ 0.00%

SIRONAX: NOVARTIS EXERCISED EXCLUSIVE OPTION TO ACQUIRE FULL GLOBAL RIGHTS TO CO'S PROPRIETARY BRAIN DELIVERY PLATFORM FOLLOWING DEAL FROM JULY 2025

Reuters·09/16/2026 11:05:38

Please log in to view news